Brief: Inhalation Sciences Unit Signs Development Agreement With Swedish Pharmaceutical Company
March 15 (Reuters) - INHALATION SCIENCES SWEDEN AB
ISAB.TE :
* UNIT ZICCUM SIGNS DEVELOPMENT AGREEMENT WITH SWEDISH
PHARMACEUTICAL COMPANY
* ORDER VALUE AT ABOUT SEK 200,000
Source text for Eikon: ID:nWkr5kgyjt
Further company coverage: ISAB.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Inhalation Sciences Sweden AB
See all newsBrief: Inhalation Sciences Gets Order Of EUR 60,000 From Long-Term Big Pharma Client
Brief: Inhalation Sciences Announces Outcome Of The Rights Issue
Brief: Inhalation Sciences Sweden Q4 Operating Loss Widens To SEK 4.3 Million
Brief: Inhalation Sciences Receives New Order From Aquilon Pharma
Brief: Inhalation Sciences Receives New Order From University Of Vienna